Table 3: Postoperative Levosimendan vs. Dobutamine groups in ventricular dysfunction in patients subjected to aortic valve replacement.

 

PARAMETER

DOBUTAMINE

LEVOSIMEDAN

‘P’ value

Cardiac frequency (lpm)

92.03 ± 16.4

92.7 ± 20.2

0.89

Systolic arterial pressure (mmHg)

101.5 ± 13.7

102.3 ± 26

0.66 *

Mean pulmonary pressure (mmHg)

26.5 ± 5.1

24.9 ± 5.8

0.24

Pulmonary capillary pressure (cmH2O)

17.03 ± 5.8

13.87 ± 2.9

0.01

Central venous pressure (cmH2O)

13.87 ± 4.1

12.1 ± 2.9

0.06

Cardiac output (L/min)

5.15 ± 1.5

5.5 ± 1.46

0.83

Cardiac Index (L/min/m2)

3.0 ± 0.8

3.2 ± 0.9

0.32

Stroke volume (cc/min)

58.5 ± 18.5

56.3 ± 18.4

0.65

Systolic index (cc/min/m2)

36.1 ± 12.7

34.9 ± 19.7

0.56 *

Systematic resistance (dinas.seg.cm-5)

969 ± 344

1018 ± 391

0.61

LVWI (g.m/m2)

34 ± 20

35 ± 45

0.34 *

Pulmonary resistance (dinas.seg.cm-5)

152 ± 78

195 ± 137

0.23 *

LVEF (%)

64.1 ± 13.6

57.6 ± 12.9

0.05

Systolic volume (cc)

52 ± 36

53 ± 36

0.87 *

Right ventricle (mm)

88.7 ± 48.4

106.7 ± 52.2

0.17

LVDD (mm)

42.3 ± 6.9

42.5 ± 9.0

0.69 *

LVSD (mm)

28.8 ± 7.6

30.5 ± 9.0

0.67 *

IVS (mm)

13.2 ± 2.4

13.6 ± 2.5

0.56

 

13.2 ± 2.7

13.3 ± 2.5

0.92

*Student T-test of independent samples.